Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro

Antimicrobial Agents and Chemotherapy
William E DelaneyShelly Xiong

Abstract

Combination therapies may be required for long-term management of some patients chronically infected with hepatitis B virus (HBV). Adefovir is a nucleotide analog that has similar activity against wild-type and lamivudine-resistant HBV. In contrast to lamivudine, clinical resistance to the prodrug adefovir dipivoxil emerges infrequently. Based on its clinical efficacy and low frequency of resistance, adefovir dipivoxil may form an important component of combination regimens. We therefore investigated the in vitro antiviral efficacy of combinations of adefovir with other nucleoside analogs (lamivudine, entecavir, emtricitabine [FTC],and telbivudine [L-dT]) and the nucleotide analog tenofovir. Using a novel stable cell line that expresses high levels of wild-type HBV, we assayed the antiviral activity of each drug alone and in combination with adefovir. All two-drug combinations resulted in greater antiviral effects than treatments with single agents and could be characterized as additive by the Bliss independence model. Analysis using the Loewe additivity model indicated that adefovir exerted additive antiviral effects when combined with lamivudine, FTC, or L-dT and moderately synergistic effects when combined with entecavir or ...Continue Reading

References

Aug 1, 1984·The Journal of Infectious Diseases·M C Berenbaum
Jul 1, 1997·Antimicrobial Agents and Chemotherapy·S F InnaimoR J Colonno
Jul 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D ColledgeT Shaw
Dec 3, 1998·Antimicrobial Agents and Chemotherapy·M SeiferD N Standring
Dec 1, 1995·Physical Review C: Nuclear Physics·N J DavisJ Gómez-Camacho
May 25, 1999·Computers and Biomedical Research, an International Journal·V DresslerJ Sühnel
Oct 21, 1999·The New England Journal of Medicine·J L DienstagN A Brown
Feb 19, 2000·Antimicrobial Agents and Chemotherapy·D ColledgeT Shaw
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·M L BryantJ P Sommadossi
Aug 31, 2001·Antiviral Chemistry & Chemotherapy·S R DasE De Clercq
Jul 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Huiling YangShelly Xiong
Jul 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Florian van BömmelThomas Berg
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Naohiro KamiyaSatoshi Yuasa
Feb 28, 2003·The New England Journal of Medicine·Stephanos J HadziyannisUNKNOWN Adefovir Dipivoxil 438 Study Group
Feb 28, 2003·The New England Journal of Medicine·Patrick MarcellinUNKNOWN Adefovir Dipivoxil 437 Study Group
Mar 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ching-Lung LaiLynn Condreay
May 23, 2003·Antimicrobial Agents and Chemotherapy·Béatrice SeignèresFabien Zoulim
Dec 4, 2003·Journal of Hepatology·Jean-Pierre VilleneuveFabien Zoulim
Jan 8, 2004·Journal of Hepatology·Solko W Schalm

❮ Previous
Next ❯

Citations

Feb 20, 2009·Advances in Therapy·Kathryn Nash
Sep 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chloe L ThioDavid L Thomas
Jun 28, 2006·Antimicrobial Agents and Chemotherapy·Xiao-Jian ZhouNathaniel A Brown
Apr 12, 2013·Journal of Virology·Matthew R CampagnaJu-Tao Guo
Oct 24, 2009·Therapeutics and Clinical Risk Management·Melissa K Osborn
Aug 29, 2007·Drugs·Susan J Keam
Sep 15, 2010·Drugs·Kate McKeage, Susan J Keam
Feb 27, 2008·World Journal of Gastroenterology : WJG·Lin-Lin GaoYan Li
Nov 1, 2006·Expert Review of Clinical Immunology·Rosa ZampinoGiuseppe Ruggiero
Jan 6, 2011·Expert Opinion on Biological Therapy·Mauro Viganò, Pietro Lampertico
Sep 28, 2005·Expert Opinion on Investigational Drugs·Chee-Kin Hui, George K K Lau
Nov 26, 2005·Current Medical Research and Opinion·Anastasia Rivkin
May 1, 2010·Biochemical and Biophysical Research Communications·Yuta WakuiTooru Shimosegawa
Nov 16, 2014·Mathematical Medicine and Biology : a Journal of the IMA·Daniela BertacchiAndrea Gori
Feb 12, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Fabien ZoulimPaul Deny
Apr 1, 2008·Alimentary Pharmacology & Therapeutics·M Kumar, S K Sarin
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David L Thomas
Aug 7, 2007·Journal of Clinical Pharmacology·Marc BifanoFrank LaCreta
Jan 8, 2008·Alimentary Pharmacology & Therapeutics·W F LeemansR A de Man
Jan 11, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Geoffrey Dusheiko
Feb 18, 2010·Liver International : Official Journal of the International Association for the Study of the Liver·Patrick MarcellinTeerha Piratvisuth
May 9, 2006·Clinical Therapeutics·S James Matthews
Jan 19, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·T E M S de Vries-SluijsM E van der Ende
Feb 8, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·David DurantelFabien Zoulim
Feb 29, 2008·Journal of Hepatology·Fabien Zoulim, Robert Perrillo
Feb 12, 2017·Gut and Liver·Young-Suk Lim
Jul 1, 2010·The Annals of Pharmacotherapy·Lauren M HynickaPunam H Patel
Mar 2, 2006·The Annals of Pharmacotherapy·Jiwon W KimStan G Louie
Apr 21, 2009·Antiviral Chemistry & Chemotherapy·Yuao ZhuKatyna Borroto-Esoda
Sep 22, 2017·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Yuka KatoTakaki Toda
Nov 30, 2004·Expert Review of Anti-infective Therapy·Tim Shaw, Stephen Locarnini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.